Export documentation and Modvat credit relief: disclosure in records defeats suppression, and rebate/refund remain admissible without double benefit.

Export documentation and statutory records that disclose the relevant facts do not support a charge of suppression or fraud, and the extended period cannot be invoked where the department already had knowledge of the material facts. The document also states that export labels prepared to meet buyer and banking requirements do not, by themselves, prove that only generic medicines were exported when the manufacturer produced both generic and P and P medicines. Where duty-paid inputs were used in manufacture, the final products were exported, and accumulated credit could not be absorbed against domestic clearances, rebate and refund of unutilized Modvat credit were stated to be admissible without any prohibited double benefit.

---

---

Issues: (i) Whether there was suppression of facts or falsification of documents to justify invocation of the extended period and demand of duty and penalty; (ii) whether the goods exported were only generic medicines or included P and P medicines; (iii) whether the rebate and refund of unutilized Modvat credit were correctly sanctioned.

Issue (i): Whether there was suppression of facts or falsification of documents to justify invocation of the extended period and demand of duty and penalty.

Analysis: The charge of suppression was tested against the record of export documentation, statutory accounts, and the contemporaneous verification by the customs officer and rebate sanctioning authority. The materials showed that the appellant had disclosed the goods in statutory records, had furnished the relevant export documents for scrutiny, and had acted in conformity with the buyer's and banking requirements. In such circumstances, concealment of material facts or deliberate misstatement was not established. The reasoning also supported the view that the extended period could not be invoked when the department had knowledge of the relevant facts.

Conclusion: The allegation of suppression failed and the extended period was not available to the department, in favour of the assessee.

Issue (ii): Whether the goods exported were only generic medicines or included P and P medicines.

Analysis: The evidence showed that the appellant manufactured both categories of medicines, that the generic clearances were negligible, and that the export labels and documents reflected the buyer's requirement for prominent display of generic names without excluding brand names. The Court accepted that export documentation prepared to satisfy foreign buyer instructions and banking formalities did not establish that the goods exported were only generic medicines. The departmental allegation was also weakened by the absence of a quantified rebuttal showing that only generic goods had been exported.

Conclusion: The finding that only generic medicines were exported was rejected, in favour of the assessee.

Issue (iii): Whether the rebate and refund of unutilized Modvat credit were correctly sanctioned.

Analysis: The undisputed facts were that duty-paid inputs were used in manufacture, the final products were exported, and the domestic clearances were too small to absorb the accumulated credit. Rule 12(1)(a) permitted rebate on exported excisable goods, while Rule 57F(13) recognized refund where credit could not be adjusted against domestic clearances. Since there was no impermissible double benefit and the statutory conditions for relief stood satisfied, the rebate and refund could not be treated as erroneous.

Conclusion: The rebate and refund were rightly sanctioned, in favour of the assessee.

Final Conclusion: The impugned order was unsustainable because the department failed to establish suppression or fraudulent export classification, and the appellant remained entitled to the export-related rebate and Modvat credit relief.

Ratio Decidendi: Where export documents and statutory records disclose the relevant facts, and the exporter satisfies the conditions for rebate and unutilized Modvat credit refund without obtaining a prohibited double benefit, mere variation in the manner of description of goods does not establish suppression or defeat export-related fiscal relief.

---